NEWPORT BEACH, CA--(MARKET WIRE)--Jun 20, 2007 -- Biomerica, Inc. (OTC BB:BMRA.OB - News), a global provider of advanced diagnostic products for the early detection of medical conditions, announces income of $697,034 on the sale of the Hollister-Stier Laboratories securities it held for investment. The Hollister-Stier securities were held as an option to purchase shares in Hollister-Stier Laboratories LLC and were carried on Biomerica’s balance sheet at a zero value as Hollister-Stier Laboratories is a private company. The acquisition of Hollister-Stier Laboratories by Jubilant Organosys Ltd. closed on June 1, 2007.
